Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myelogenous Leukemia

Clinical trial condition

Acute Myelogenous Leukemia

Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

154 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Acute Myelogenous Leukemia trial results

Not Yet Recruiting

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

NCT07157514

Conditions: Acute Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Role of BMP Pathway in MDS Progression

NCT06175923

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Hospices Civils de Lyon Lyon, France

View Trial Details

Completed

Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission

NCT01096602

Conditions: AML, Acute Myelogenous Leukemia, Hematologic Diseases, +6 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

NCT02719574

Conditions: Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +9 more
Locations: UCLA Medical Center Los Angeles, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

Yale University New Haven, Connecticut, United States

University of Miami Miami, Florida, United States

View all 60 locations

View Trial Details

Completed

LILRB4 STAR-T Cell Therapy for Monocytic Leukemia

NCT05739409

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Completed

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

NCT02996773

Conditions: Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Resiliency in Older Adults Undergoing Bone Marrow Transplant

NCT04188678

Conditions: Acute Myelogenous Leukemia, Blood Cancer, Bone Marrow Diseases, +18 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Epigenetic Reprogramming in Relapse/Refractory AML

NCT03263936

Conditions: Acute Myelogenous Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Orange County Orange, California, United States

UCSF School of Medicine San Francisco, California, United States

The Children's Hospital, University of Colorado Aurora, Colorado, United States

View all 33 locations

View Trial Details

Completed

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

NCT01660607

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia, +28 more
Locations: Stanford University School of Medicine Palo Alto, California, United States Palo Alto, California, United States

View Trial Details

Completed

Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)

NCT01385423

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details